Breast Cancer Gene ReviewedSeptember 25, 2002PRESS CONFERENCE - 0930 H Thursday 26 September at Cancer Research UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK; Further information from Cancer Research UK Press Office (see below). A review article in this week's issue of THE LANCET assesses the impact of BRCA1 gene mutations-known to be strongly associated with an increased risk of breast and ovarian cancer-on the management of patients. The BRCA1 gene was identified in 1990 and cloned in 1994. Around 1 in 500 to 1 in 800 women have a BRCA1 gene mutation; women with familial breast or ovarian cancer have a germline mutation of the gene, which gives them a lifetime risk of breast cancer of around 50-85%, and ovarian cancer of 15-60%. Although a genetic test for identification of high-risk individuals has been developed, the underlying mechanisms of how inactivation of the BRCA1 gene leads to malignant cell growth is not fully understood. . Paul Harkin and Richard Kennedy from Queens University, Belfast, UK, and colleagues examine the mechanisms that underlie inactivation of BRCA1 and assess how they affect the management of patients, in terms of both primary (eg. Prophylactic surgery such as mastectomy or oopherectomy and preventative use of drug therapy) and secondary cancer prevention strategies (eg. Early identification and treatment of tumours). The authors also assess the potential usefulness of BRCA1 as a prognostic tool and as a predictive marker of response to different classes of drugs. Richard Kennedy comments: "The association between dysfunction of BRCA1 and the development of cancer emphasises the importance of the application of modern molecular biology to clinical practice. The identification of BRCA1 and the understanding of its role and function have greatly changed patients' management." Paul Harkin adds: "It will become increasingly important over the next few years to relate clinical findings to the underlying molecular biology of cancer, and to find clinically relevant applications for the discovery of new genes and molecular pathways in the laboratory. Only in this way can innovative cancer treatments be rationally designed and tested." | |||||||||||||||||||||
|
Related Cancer News Articles New insights into the regulation of PTEN tumor suppression function The PTEN tumor suppressor gene controls numerous biological processes including cell proliferation, cell growth and death. But PTEN is frequently lost or mutated; in fact, alteration of the gene is so common among various types of human cancer that PTEN has become one of the most frequently mutated of all tumor suppressors. Researchers discover how rheumatoid arthritis causes bone loss Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. Making 'good' fat from muscle and vice versa A surprise discovery -- that calorie-burning brown fat can be produced experimentally from muscle precursor cells in mice -- raises the prospect of new ways to fight obesity and overweight, say scientists from Dana-Farber Cancer Institute. Researchers discover scent of skin cancer According to new research from the Monell Center, odors from skin can be used to identify basal cell carcinoma, the most common form of skin cancer. The findings, presented at the 236th meeting of the American Chemical Society, may open doors to development of new methods to detect basal cell carcinoma and other forms of skin cancer. Cervical cancer prevention should focus on vaccinating adolescent girls The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by revising current screening policies. Obesity raises risks of serious digestive health concerns The prevalence of obesity and overweight in the United States coupled by the increased risk of gastrointestinal diseases related to obesity raises serious implications for the health of Americans. Bowel cancer indicator should lead to better treatment STEM cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Stem cell indicator for bowel cancer should lead to better survival rates Stem cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Bowel cancer is the third most common cancer in the UK. Infection Blocks Lung's Protective Response Against Tobacco Smoke An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health. NYU scientists identify critical protein complex in formation of cell cilia An international team led by NYU Cancer Institute have identified a protein complex that regulates the formation of cilia, which are found on virtually all mature human cells and are essential to normal cell function. More Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||